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*Acinetobacter baumannii* is a nosocomial pathogen normally classified as multidrug resistant (MDR). Alarmingly, the number of MDR *A. baumannii* isolates has increased in the last few years, making it a difficult microorganism to treat ([@B1], [@B2]), as infections caused by it are associated with high rates of mortality and long periods of hospitalization ([@B3]). The rates of *Acinetobacter* species MDR isolates in Latin America have increased lately, as resistance to imipenem in Chile increased from 0.0% during 1997 to 1999, to 47.4% in the 2008 to 2010 period ([@B4]), and 65.8% in 2014 (Antibiotic Resistant Group from Chilean Society for Infectious Diseases, personal communication).

In this work, we studied the genetic features of the *A. baumannii* MDR strain Ab5 through whole-genome sequencing (WGS), as this was one of the first sentinel cases of MDR isolates in Chile. To date, there are no whole-genome sequences of *A. baumannii* strains from Chile available in GenBank. The Ab5 strain was isolated at the Hospital of the Catholic University of Santiago in 2007 from a patient who developed a wound infection. Diverse antibiotics were tested by the disk diffusion method and by the agar dilution test, according to the Clinical and Standards Institute (CLSI) guidelines ([@B5]). Ab5 was found to be resistant to ceftazidime, imipenem, meropenem, gentamicin, cefotaxime, ciprofloxacin, cefepime, and piperacillin-tazobactam. The MICs to carbapenems were 8 µg/ml to meropenem and 16 µg/ml to imipenem.

WGS was performed utilizing the Illumina HiSeq 2000 platform. The data generated were assembled using the Velvet assembly pipeline ([@B6]), with contigs \>200 bp, resulting in 107 contigs, a total length of 3,937,075 bp, and an *N*~50~ contig size of 173,003 bp; meanwhile, the average G+C content was 38.9%, coinciding with the data associated with the *Acinetobacter* genus.

Genome annotation was performed utilizing the Rapid Annotations using Subsystems Technology (RAST) ([@B7]), and the IGS Annotation Engine was used for structural and functional annotation ([@B8]). Manatee was used to view annotations (<http://manatee.sourceforge.net>/), while ResFinder ([@B9]), PathogenFinder ([@B10]), and multilocus sequence typing (MLST) of total genome-sequenced bacteria ([@B11]) were utilized for complementary analyzes.

We identified 3,657 coding sequences (CDSs), 57 pseudogenes, 7 rRNAs, and 57 tRNAs. Additionally, Ab5 belonged to sequence type 162 (ST-162), which was previously detected in Brazil. We identified the *bla*~OXA-58~, *bla*~OXA-51~, *aph*(3′)-Via, and the DNA topoisomerase type II genes that might explain its MDR phenotype. Interestingly, we found genes associated with iron acquisition, such as the *pitADC*, *piaABC*, and *piuABC* operons, which have been identified in *Streptococcus pneumoniae*. We also identified 25 pathogenesis-associated operons derived from *Mycobacterium* spp., whereas one detected operon, involved in internalin-like proteins synthesis, may have been imported from *Listeria*.

This first approach reflects the ability of *A. baumannii* to capture a wide range of genes derived from different species, making it a troublesome pathogen to treat in the nosocomial environment.
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This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. [LANH00000000](LANH00000000). The version described in this paper is version LANH01000000.
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